Clear Street’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Clear Street’s Portfolio DMIIR Stock Details DMIIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.8K	Buy	297,716 +154,745	+108%	+$13.2K	﹤0.01%	1099
2026 Q1	$11.4K	Buy	142,971 +115,712	+424%	+$13.1K	﹤0.01%	942
2025 Q4	$3.82K	Buy	+27,259	New	+$3.89K	﹤0.01%	830

Other funds holding DMIIR

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Clear Street's DMIIR Position: Q2 2026 in Review

Clear Street increased its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 108% in Q2 2026, buying an estimated $13.2K and bringing the position to 297,716 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Clear Street first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. 61 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

Clear Street held 297,716 shares of Drugs Made In America Acquisition II Corp Right worth $23.8K as of Q2 2026.
Clear Street bought 154,745 Drugs Made In America Acquisition II Corp Right shares in Q2 2026, an estimated $13.2K.
Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1099 holding.
Clear Street first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
61 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.